Page last updated: 2024-08-26

strontium and Secondary Hyperparathyroidism

strontium has been researched along with Secondary Hyperparathyroidism in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bräuner-Osborne, H; Jacobsen, SE; Latta, M; Stahlhut, M; Thomsen, AR; Worm, J	1
Cannata Andía, JB; Fernández Martín, JL; García Alonso, JI; Gerstenfeld, S; Hinojosa, L; Marchante, JM; Menéndez Rodríguez, P; Sanz-Medel, A; Serrano Arias, M	1
Ardissino, G; Bianchi, ML; Claris-Appiani, A; Daccò, V; Mehls, O; Schmitt, CP	1
Balasubramaniam, P; Jowsey, J	1
Joplin, GF; Thalassinos, NC; Wicht, S	1

Trials

1 trial(s) available for strontium and Secondary Hyperparathyroidism

Article	Year
No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure. Kidney international, 2000, Volume: 58, Issue:3 Topics: Administration, Oral; Adolescent; Calcitriol; Calcium; Calcium Channel Agonists; Child; Child, Preschool; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Strontium	2000

Article

Year

No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.

Kidney international, 2000, Volume: 58, Issue:3

Topics: Administration, Oral; Adolescent; Calcitriol; Calcium; Calcium Channel Agonists; Child; Child, Preschool; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Strontium

2000

Other Studies

4 other study(ies) available for strontium and Secondary Hyperparathyroidism

Article	Year
Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:3 Topics: Animals; Calcitonin; Calcium; Carcinoma, Neuroendocrine; Cell Line, Tumor; HEK293 Cells; Humans; Hyperparathyroidism, Secondary; Rats; Receptors, Calcium-Sensing; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Strontium; Thyroid Neoplasms	2012
[Effect of strontium on bone metabolism in hemodialysis patients]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003, Volume: 23 Suppl 2 Topics: Alkaline Phosphatase; Argentina; Biopsy; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Ilium; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Portugal; Renal Dialysis; Spain; Strontium	2003
Effect of phosphate supplements on soft-tissue calcification and bone turnover. Clinical science, 1972, Volume: 42, Issue:3 Topics: Administration, Oral; Animals; Aorta, Thoracic; Bone and Bones; Bone Resorption; Calcinosis; Calcium; Calcium, Dietary; Diet; Femur; Hyperparathyroidism, Secondary; Kidney; Microradiography; Phosphates; Rabbits; Strontium; Strontium Isotopes; Tibia	1972
Secondary hyperparathyroidism in osteomalacia. British medical journal, 1970, Jan-10, Volume: 1, Issue:5688 Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Female; Hand; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphates; Radiography; Strontium	1970